Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Laboratory Corporation of America Holdings

NYSE: LHHealthcare / Medical Laboratories & Research / USA
141.06+0.2100+0.15%Vol 110 7811Y Perf -9.55%
Dec 13th, 2018 10:10
BID141.03 ASK141.22
Open141.72 Previous Close140.85
Pre-Market- After-Trading140.85
 - -%  - -%
Target Price
176.21 
Analyst Rating
Moderate Buy 2.03
Potencial %
24.72 
Finscreener Ranking
★★★     51.00
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★★     59.20
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★     58.76
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)14 233 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
9.06 
Earnings Date
5th Feb 2019

Today's Price Range

140.67141.89

52wk Range

136.15190.35

5 Year PE Ratio Range

14.0033.30

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-14.35%
3 Months
-18.36%
6 Months
-24.98%
1 Year
-9.55%
3 Years
16.24%
5 Years
58.03%

Quotes

Name / TickerPriceChg.Chg.%
LH141.060.21000.15
AAPL171.732.63001.56
GOOG1 073.589.90000.93
MSFT110.351.27001.16
XOM76.690.67000.88
WFC47.55-0.1900-0.40
JNJ148.241.14000.77
FB145.200.70000.48
GE7.380.67009.99
JPM101.250.23000.23
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.30
Current Ratio
1.60
Long Term Debt to Total Capital
0.45
Total Debt to Equity
0.89
Interest Coverage
6.40
Leverage Ratio 2.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
31.50
EBIT Margin
14.30
EBITDA Margin
19.20
Pre-tax Profit Margin
12.00
Profit Margin
12.95
ValuationValueIndustryS&P 500US Markets
PE Ratio
10.10
PB Ratio
1.98
PS Ratios
1.27
Price to Cash Flow
10.90
Price to Free Cash Flow
16.90
Cash Flow Per Share
13.02
Price to Tangible Book
-3.49
Book Value per Share
71.83
Enterprise Value (in ths.)
19 893 600
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
17.15
ROE last 12 Months
21.75
Return on Assets (5Y Avg)
4.22
ROA last 12 Months
8.72
Return on Capital (5Y Avg)
9.69
ROC last 12 Months
12.44
Return on invested Capital Q
2.62
Return on invested Capital Y
11.82
Assets Turnover
0.30
Receivables Turnover
2.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
11 247 400
Revenue per Share
111.47
Revenue Growth 3 Years
9.62
Revenue Growth 5 Years
14.85
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 20182.872.74-4.53
Q02 20182.922.982.05
Q01 20182.642.785.30
Q04 20172.372.453.38
Q03 20172.382.463.36
Q02 20172.382.473.78
Q01 20172.192.221.37
Q04 20162.132.150.94
Earnings Per EndEstimateRevision %Trend
12/2018 QR2.48-13.89Negative
12/2018 FY10.99-4.68Negative
3/2019 QR2.69-5.61Negative
12/2019 FY11.24-6.49Negative
Next Report Date5th Feb 2019
Estimated EPS Next Report2.48
Estimates Count10
EPS Growth Next 5 Years %8.90
Volume Overview
Volume110 781
Shares Outstanding (in ths.)100 900
Trades Count957
Dollar Volume21 455 553
Avg. Volume751 189
Avg. Weekly Volume955 731
Avg. Monthly Volume1 067 413
Avg. Quarterly Volume882 166

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (44.44 %)
10 (55.56 %)
11 (68.75 %)
Moderate Buy
1 (5.56 %)
1 (5.56 %)
1 (6.25 %)
Hold
9 (50.00 %)
7 (38.89 %)
4 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.03
Moderate Buy
1.81
Strong Buy
1.53

There are no comments yet.

News